Menu

Resources

November 12, 2015

Bio-Pharma Developments: Bass, Biologics, and Small Molecules

The use of IPR challenges in the bio-pharma space continues to grow. Fish speakers Dorothy Whelan and Tasha Francis  discussed the latest noteworthy developments. Topics included the Bass hedge fund filings and the PTAB’s decision not to prohibit such filings as an abuse of process. Additional topics reviewed were: recent institutions and final written decisions, including presenting pointers for both petitioners and patent owners.

Speakers:
Dorothy Whelan, Principal
Tasha Francis, Associate
Download Presentation Slides
For audio-only (MP3 format), click here to launch in a new window, or right-click and choose “Save link/target as” to download to your computer.

No Comments

Sorry, the comment form is closed at this time.

Fill out the form below to receive our monthly newsletter and updates on your selected areas of interest. You can unsubscribe at any time by clicking the unsubscribe link at the bottom of the email.

  • Fish & Richardson P.C. is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the services you requested from us. From time to time, we would like to contact you about our services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below.
  • In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.
  • You can unsubscribe from these communications at any time. This can be done by clicking the unsubscribe link at the bottom of marketing emails you receive from us, or by emailing info@fr.com stating that you would like to be unsubscribed.
  • This field is for validation purposes and should be left unchanged.